452 related articles for article (PubMed ID: 19897039)
21. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
Shah KM; Young LS
Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
[TBL] [Abstract][Full Text] [Related]
22. [Epstein-Barr virus and Burkitt's lymphoma].
Joab I
Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
[TBL] [Abstract][Full Text] [Related]
23. Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response.
Dias MHF; Guimarães LFF; Barcelos MG; Moreira EUM; do Nascimento MFA; de Souza TN; Pires CV; Monteiro TAF; Middeldorp JM; Soares IS; Fontes CJF; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010305. PubMed ID: 35921373
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.
Bornkamm GW
Semin Cancer Biol; 2009 Dec; 19(6):351-65. PubMed ID: 19619654
[TBL] [Abstract][Full Text] [Related]
25. Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children.
Reynaldi A; Schlub TE; Chelimo K; Sumba PO; Piriou E; Ogolla S; Moormann AM; Rochford R; Davenport MP
J Infect Dis; 2016 Mar; 213(6):985-91. PubMed ID: 26531246
[TBL] [Abstract][Full Text] [Related]
26. From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases.
Okano M; Gross TG
Pediatr Hematol Oncol; 2001; 18(7):427-42. PubMed ID: 11594706
[TBL] [Abstract][Full Text] [Related]
27. The etiology of Burkitt's lymphoma and the history of the shaken dogmas.
de Thé G
Blood Cells; 1993; 19(3):667-73; discussion 674-5. PubMed ID: 8018947
[TBL] [Abstract][Full Text] [Related]
28. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
29. Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation.
Chattopadhyay PK; Chelimo K; Embury PB; Mulama DH; Sumba PO; Gostick E; Ladell K; Brodie TM; Vulule J; Roederer M; Moormann AM; Price DA
J Virol; 2013 Feb; 87(3):1779-88. PubMed ID: 23175378
[TBL] [Abstract][Full Text] [Related]
30. AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus.
Wilmore JR; Asito AS; Wei C; Piriou E; Sumba PO; Sanz I; Rochford R
Int J Cancer; 2015 Mar; 136(6):1371-80. PubMed ID: 25099163
[TBL] [Abstract][Full Text] [Related]
31. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
[TBL] [Abstract][Full Text] [Related]
32. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
[TBL] [Abstract][Full Text] [Related]
33. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
Araujo I; Foss HD; Hummel M; Anagnostopoulos I; Barbosa HS; Bittencourt A; Stein H
J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
[TBL] [Abstract][Full Text] [Related]
35. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
36. [Epstein-Barr virus and associated diseases. Course of Medical Virology, Institut Pasteur, 1995/1996].
de Thé G
Ann Med Interne (Paris); 1997; 148(5):357-66. PubMed ID: 9538409
[TBL] [Abstract][Full Text] [Related]
37. Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.
Moormann AM; Bailey JA
Curr Opin Virol; 2016 Oct; 20():78-84. PubMed ID: 27689909
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus-associated lymphomas.
Gandhi MK
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus and Burkitt lymphoma.
Brady G; Macarthur GJ; Farrell PJ
Postgrad Med J; 2008 Jul; 84(993):372-7. PubMed ID: 18716017
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus behavior in different populations and implications for control of Epstein-Barr virus-associated tumors.
de-Thé G
Cancer Res; 1976 Feb; 36(2 pt 2):692-5. PubMed ID: 1253156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
